Applying Evidence to Practice: VTE Prevention and Thrombophilia Testing for Surgical and Non-Surgical Patients - UPMC Hamot
The purpose of this course is to provide the latest updates and practice guidelines in VTE prevention and thrombophilia testing.
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Upon completion of this activity, participants should be able to:
- Compare and contrast clinical trial and observational evidence for VTE prevention in major orthopedic surgery
- Review appropriate VTE prevention strategies for patients undergoing major orthopedic surgery.
- Discuss when thrombophilia testing is appropriate for hospitalized patients Interpret thrombophilia test results for patients with acute VTE
Geoffrey Barnes , MD, MSc - Assistant Professor, Internal Medicine, Vascular and Cardiovascular Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI
Planning Committee Members:
- Robert Maholic, DO, Cardiologist, UPMC-Hamot Heart Institute, Erie, PA.
- Deborah Pora, CRNP, Erie, PA
- Maryann Scholl, PharmD, Assistant Professor of Pharmacy Practice at LECOM
- Samantha Jenkins, PAC, Erie, PA
Dr. Barnes is a consultant with Pfizer/Bristol-Myers Squibb, Jansen, AMAG Pharmaceuticals, and Acelis Connected Health. He is on the Board of Directors for Anticoagulation form. He receives grant funding from Blue Cross Blue Shield of Michigan, NHLBI and AHRQ.
Dr. Maholic is a consultant for Boston Scientific.
No other relationships with industry relevant to the content of this educational activity have been disclosed.
Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 1.00 AAPA Category I CME
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance